Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene

被引:8
|
作者
Li, Rong [1 ]
Baskfield, Amanda [1 ]
Lin, Yongshun [2 ]
Beers, Jeanette [2 ]
Zou, Jizhong [2 ]
Liu, Chengyu [3 ]
Jaffre, Fabrice [4 ]
Roberts, Amy E. [5 ]
Ottinger, Elizabeth A. [1 ]
Kontaridis, Maria I. [6 ,7 ,8 ]
Zheng, Wei [1 ]
机构
[1] NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA
[2] NHLBI, IPSC Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Weill Cornell Med Coll, Dept Surg, New York, NY USA
[5] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA
[6] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA
[7] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[8] Mason Med Res Inst, 2150 Bleecker St, Utica, NY 13501 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.scr.2018.101374
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Noonan syndrome with multiple lentigines (NSML), formerly known as LEOPARD Syndrome, is a rare autosomal dominant disorder. Approximately 90% of NSML cases are caused by missense mutations in the PTPN11 gene which encodes the protein tyrosine phosphatase SHP2. A human induced pluripotent stem cell (iPSC) line was generated using peripheral blood mononuclear cells (PBMCs) from a patient with NSML that carries a gene mutation of p.Q510P on the PTPN11 gene using non-integrating Sendai virus technique. This iPSC line offers a useful resource to study the disease pathophysiology and a cell-based model for drug development to treat NSML.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines LEOPARD syndrome and Noonan-like multiple giant cell lesion syndrome
    Sarkozy, A
    Obregon, MG
    Conti, E
    Esposito, G
    Mingarelli, R
    Pizzuti, A
    Dallapiccola, B
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (12) : 1069 - 1072
  • [2] A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome
    Anna Sarkozy
    Maria Gabriela Obregon
    Emanuela Conti
    Giorgia Esposito
    Rita Mingarelli
    Antonio Pizzuti
    Bruno Dallapiccola
    European Journal of Human Genetics, 2004, 12 : 1069 - 1072
  • [3] Noonan syndrome with multiple lentigines with PTPN11 (T468M) gene mutation accompanied with solitary granular cell tumor
    Park, Seh Hyun
    Lee, Si-Hyung
    JOURNAL OF DERMATOLOGY, 2017, 44 (11): : E280 - E281
  • [4] Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene
    Hong, Junjie
    Xu, Miao
    Li, Rong
    Cheng, Yu-Shan
    Kouznetsova, Jennifer
    Beers, Jeanette
    Liu, Chengyu
    Zou, Jizhong
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 37
  • [5] Generation of human induced pluripotent stem cell lines derived from three Noonan syndrome patients from a single family carrying the heterozygous PTPN11 c.188 A > G (p.Y63C) mutation
    Sbrini, Giulia
    Tomasoni, Zaira
    Cutri, Maria Rosa
    Pilotta, Alba
    Mingotti, Chiara
    Badolato, Raffaele
    La Via, Luca
    Barbon, Alessandro
    Bono, Federica
    Fiorentini, Chiara
    STEM CELL RESEARCH, 2024, 74
  • [6] An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene
    Huang, Wei
    Xu, Miao
    Li, Rong
    Baskfield, Amanda
    Kouznetsova, Jennifer
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 37
  • [7] Generation of an Alagille Syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi036-A) carrying a heterozygous mutation (p.Cys693*) in the JAG1 gene
    Hatim, Omer
    Xu, Miao
    Pavlinov, Ivan
    Linask, Kaari
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Rodems, Steven
    Baumgartel, Karsten
    Gilbert, Melissa A.
    Spinner, Nancy B.
    Chen, Catherine
    Zheng, Wei
    STEM CELL RESEARCH, 2024, 77
  • [8] An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene
    Yang, Shu
    Cheng, Yu-Shan
    Li, Rong
    Pradhan, Manisha
    Hong, Junjie
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Might, Matt
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 39
  • [9] A novel variant in PTPN11, c.1277A>G p.(His426Arg), in a patient with Noonan syndrome with multiple lentigines
    Kuo, Olivia
    Molloy, Kevin
    Sabir, Ataf
    Fleming, Andrew
    Edwards, Matthew
    Morris-Rosendahl, Deborah
    Fassihi, Hiva
    Preston, Philip
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (09) : 1101 - 1103
  • [10] Generation of an induced pluripotent stem cell line from a patient with Angelman syndrome carrying UBE3A mutation
    Li, Shasha
    Zhu, Qunyan
    Cai, Yaoyao
    Yang, Qian
    STEM CELL RESEARCH, 2022, 62